Smiths Medical, has released the CADDSolis ambulatory infusion pump version 4.1, which the medical device manufacturer says sets the foundation for wireless communication globally.
The CADD-Solis v4.1 pump is ULmarked and has full compliance with the latest product standards, including IEC60601-1 Edition 3.1. The CADD-Solis pump maintains the advantages of an ambulatory pump for patient mobility and also provides a single system that delivers IV PCA, epidurals and peripheral nerve blocks from pump to patient.
New features include: longer drug names to eliminate abbreviating or truncating drug names and concentrations; the addition of profiles to categorise drug protocols or represent care areas; and wireless two-way communication with the PharmGuard Server software.
Users can continue to use previous versions or choose to upgrade any CADD-Solis model 2110 pump2 to CADD-Solis v4.1 software, using SureLink remote support software, while maintaining their existing drug library. Turning off wireless communications or the lack of wireless access does not impact pump delivery or data retention.
More about Smiths Medical Ltd